Mavyret 40 mg/1

Mavyret 40 mg/1 is a combination medication used to treat certain types of hepatitis C virus (HCV) infections. This oral tablet contains glecaprevir and pibrentasvir, designed for convenient once-daily dosing.

Mavyret 40 mg/1 is primarily used for the treatment of chronic hepatitis C virus (HCV) infection. This medication is often prescribed for adults with specific genotypes of HCV, aiming to reduce the viral load in the body. Patients may wonder, 'What is Mavyret used for?'—it is typically used as part of a comprehensive treatment plan to manage HCV.

Common effects of Mavyret 40 mg/1 may include fatigue, headache, and nausea. Some individuals might experience changes in their liver function tests. It's important to monitor these effects and consult a healthcare provider if they persist or worsen.

Mavyret 40 mg/1 should be handled with care, especially for those with liver disease or other medical conditions. It is crucial to follow the prescribed dosage and administration guidelines. Patients should avoid alcohol and certain medications that may interact with Mavyret.

Mavyret 40 mg/1 may interact with other medications, including those metabolized by the liver. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements, to avoid potential interactions.